[HTML][HTML] It's time to die: BH3 mimetics in solid tumors

S Kehr, M Vogler - Biochimica et Biophysica Acta (BBA)-Molecular Cell …, 2021 - Elsevier
The removal of cells by apoptosis is an essential process regulating tissue homeostasis.
Cancer cells acquire the ability to circumvent apoptosis and survive in an unphysiological …

Molecular pathogenesis and diagnostics of bladder cancer

AP Mitra, RJ Cote - Annual Review of Pathology: Mechanisms of …, 2009 - annualreviews.org
Despite elaborate characterization of the risk factors, bladder cancer is still a major
epidemiological problem whose incidence continues to rise each year. Urothelial carcinoma …

Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumors

SC Parte, SK Batra, SS Kakar - Journal of Ovarian Research, 2018 - Springer
Background Ovarian cancer is a complicated malady associated with cancer stem cells
(CSCs) contributing to 238,700 estimated new cases and 151,900 deaths per year …

NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo

X Cui, D Shen, C Kong, Z Zhang, Y Zeng, X Lin… - Scientific reports, 2017 - nature.com
Nuclear factor kappa-B (NF-κB) activation is a common phenomenon in cancers, which
results in the aberrant expression of NF-κB target genes and leads to malignant …

Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival

CL Chen, L Cen, J Kohout, B Hutzen, C Chan… - Molecular cancer, 2008 - Springer
Background Constitutive activation of signal transducer and activator of transcription 3
(Stat3) signaling pathway plays an important role in several human cancers. Activation of …

Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type-and mutation-specific manner

E Di Martino, CG L'hôte, W Kennedy, DC Tomlinson… - Oncogene, 2009 - nature.com
Although activating mutations of fibroblast growth factor receptor 3 (FGFR3) are frequent in
bladder tumors, little information is available on their specific effects in urothelial cells or the …

Biomarkers in bladder cancer: translational and clinical implications

L Cheng, DD Davison, J Adams… - Critical reviews in …, 2014 - Elsevier
Bladder cancer is associated with high recurrence and mortality rates. These tumors show
vast heterogeneity reflected by diverse morphologic manifestations and various molecular …

Generation of a concise gene panel for outcome prediction in urinary bladder cancer

AP Mitra, V Pagliarulo, D Yang, FM Waldman… - Journal of clinical …, 2009 - ascopubs.org
Purpose This study sought to determine if alterations in molecular pathways could
supplement TNM staging to more accurately predict clinical outcome in patients with …

Expression and prognostic significance of bcl-2 and bax in the progression and clinical outcome of transitional bladder cell carcinoma

BG Eimani, MH Sanati, M Houshmand… - Cell Journal …, 2013 - pmc.ncbi.nlm.nih.gov
Objective: To evaluate the mRNA expression ratio of Bcl-2/Bax both in normal and tumoral
bladder tissues of patients with transitional cell carcinoma (TCC) of bladder and investigate …

Molecular markers for bladder cancer: the road to a multimarker approach

M Birkhahn, AP Mitra, RJ Cote - Expert review of anticancer …, 2007 - Taylor & Francis
Bladder cancer is the seventh most common malignancy worldwide, with almost 14,000
patients dying from this disease in the USA alone. Because of the need for long-term and …